Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2005 3
2006 1
2007 1
2008 2
2009 4
2010 12
2011 8
2012 8
2013 6
2014 9
2015 6
2016 2
2017 1
2018 2
2019 2
2023 5
2024 2
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Muscle growth by sarcomere divisions.
Rodier C, Estabrook ID, Chan EH, Rice G, Loreau V, Raunser S, Görlich D, Friedrich BM, Schnorrer F. Rodier C, et al. Among authors: chan eh. Sci Adv. 2025 Jul 11;11(28):eadw9445. doi: 10.1126/sciadv.adw9445. Epub 2025 Jul 9. Sci Adv. 2025. PMID: 40632866 Free PMC article.
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion.
Mercier BD, Govindarajan A, Castro DV, Li X, Philip EJ, Feng MI, Prajapati SR, Chan EH, Lee KO, Sehgal I, Patel J, O'Dell A, Chehrazi-Raffle A, Ebrahimi H, Rock A, Zengin ZB, Meza LA, Dizman N, Hsu J, Liu S, Dorff TB, Pal SK, Tripathi A. Mercier BD, et al. Among authors: chan eh. Cancer Med. 2025 Apr;14(7):e70696. doi: 10.1002/cam4.70696. Cancer Med. 2025. PMID: 40145383 Free PMC article.
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
Castro DV, Prajapati SR, Feng MI, Chan EH, Lee KO, Paul T, Sehgal I, Patel J, Li X, Zengin ZB, Ebrahimi H, Govindarajan A, Meza L, Mercier BD, Chawla NS, Dizman N, Philip EJ, Hsu J, Bergerot CD, Chehrazi-Raffle A, Rock A, Liu S, Tripathi A, Dorff TB, Pal SK. Castro DV, et al. Among authors: chan eh. BJU Int. 2024 Mar;133(3):297-304. doi: 10.1111/bju.16148. Epub 2023 Sep 1. BJU Int. 2024. PMID: 37548533
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma.
Dizman N, Govindarajan A, Zengin ZB, Meza L, Tripathi N, Sayegh N, Castro DV, Chan EH, Lee KO, Prajapati S, Feng M, Loo V, Pace M, O'Brien S, Bailey E, Barragan-Carrillo R, Chehrazi-Raffle A, Hsu J, Li X, Agarwal N, Pal SK. Dizman N, et al. Among authors: chan eh. Clin Genitourin Cancer. 2023 Oct;21(5):530-536. doi: 10.1016/j.clgc.2023.06.004. Epub 2023 Jun 25. Clin Genitourin Cancer. 2023. PMID: 37495481
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research.
Ebrahimi H, Castro DV, Feng MI, Prajapati SR, Lee KO, Chan EH, Paul T, Sehgal I, Patel J, Li X, Zengin ZB, Meza L, Mercier BD, Hsu J, Govindarajan A, Chawla N, Dizman N, Bergerot CD, Rock A, Liu S, Tripathi A, Dorff T, Pal SK, Chehrazi-Raffle A. Ebrahimi H, et al. Among authors: chan eh. Clin Genitourin Cancer. 2023 Dec;21(6):e467-e473. doi: 10.1016/j.clgc.2023.05.013. Epub 2023 May 24. Clin Genitourin Cancer. 2023. PMID: 37301665
71 results